Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 209

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 209
---
 2023                                                        |     |   |  4,331,815 |   |
| Issuance of shares through Equity Line of Credit (Note 2)                              |     |   |  1,936,236 |   |
| Issuance of shares through conversion of convertible notes                             |     |   |  2,650,000 |   |
| Decrease in subscription receivable due to reduction of work by professionals (Note 1) |     |   | (2,766,856 | ) |
| Business Combination (Note 3)                                                          |     |   | (6,028,690 | ) |
| Balance as at December 31, 2024                                                        |     | $ |    122,505 |   |

| * | -                                                                                              
 the number of shares below have been amended to apply the two reverse stock splits in February 
 2025 and in May 2025 retrospectively.                                                          |

Note 1:

Note 2: On November 21, 2024, the Company
entered into a Common Shares Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC (“White
Lion”) and a related Registration Rights Agreement (the “RRA”). Pursuant to the White Lion Purchase Agreement, the Company
has the right, but not the obligation, to require White Lion to purchase, within 36 months from the Agreement effective date up to One
Hundred Million Dollars ($) in aggregate gross purchase price of newly issued Ordinary Shares, with an automatic increase to
Three Hundred Million Dollars ($) upon any substantial M&A or Material Transaction (as defined in the White Lion Purchase
Agreement) and a further option to increase to Five Hundred Million Dollars ($) after Two Hundred and Fifty Million Dollars
($) has been issued and sold to White Lion under the White Lion Purchase Agreement, subject to certain limitations and conditions
set forth in the White Lion Purchase Agreement. The White Lion Purchase Agreement was included as Exhibit 10.27 of the Form F-1 registration
statement filed on December 5, 2024.

On December 10, 2024, Class A Ordinary
Shares were issued to White Lion amounting $, in consideration for White Lion’s commitment pursuant to the White Lion Purchase
Agreement. In addition, on December 12, 2024, pursuant to this Agreement, the Company issued Class A Ordinary Shares for a purchase
price of $. On December 24, 2024, the Company issued Class